Yes, as of March 2017 Symproic (naldemedine) is classified by the DEA as a schedule II narcotic because it can be abused or lead to drug-seeking behavior and addiction. Although Symproic is currently a Schedule II controlled substance, the manufacturer has asked the DEA to review removing the drug from scheduling.
Symproic is an oral medication used to treat opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. Keep this medicine in a safe place to prevent misuse and abuse.
Subscribe to receive email notifications whenever new articles are published.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Oct 1st, 2018), Cerner Multum™ (updated Oct 2nd, 2018), Wolters Kluwer™ (updated Oct 2nd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.